Iron Deposition in Parkinson’s Disease: A Mini-Review
Cellular and Molecular Neurobiology · 2024-12 · 44 (1)
DOI: 10.1007/s10571-024-01459-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular and Molecular Neurobiology, online erschienen am 23.02.2024. Verfasst von Weiqi Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First People's Hospital of Foshan, Foshan, China. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Iron deposition is crucial pathological changes observed in patients with Parkinson's disease (PD). Recently, scientists have actively explored therapeutic approaches targeting iron deposition in PD. However, several clinical studies have failed to yield consistent results. In this review, we provide an overview of iron deposition in PD, from both basic research and clinical perspectives. PD patients exhibit abnormalities in various iron metabolism-related proteins, leading to disruptions in iron distribution, transport, storage, and circulation, ultimately resulting in iron deposition. Excess iron can induce oxidative stress and iron-related cell death, and exacerbate mitochondrial dysfunction, contributing to the progression of PD pathology. Magnetic resonance imaging studies have indicated that the characteristics of iron deposition in the brains of PD patients vary. Iron deposition correlates with the clinical symptoms of PD, and patients with different disease courses and clinical presentations display distinct patterns of iron deposition. These iron deposition patterns may contribute to PD diagnosis. Iron deposition is a promising target for PD treatment. However, further research is required to elucidate the underlying mechanisms and their impacts on PD. Graphical Abstract Iron deposition in the Substantia nigra (SN) is a crucial pathological alteration in Parkinson's disease (PD). This article provides a review of the mechanisms and effects of iron deposition, as well as research on brain iron deposition in PD patients using magnetic resonance imaging (MRI). These findings elucidate the role of iron deposition in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First People's Hospital of Foshan, Foshan, China.
- Department of Cardiology, The Second Hospital of Zhangzhou, Zhangzhou, China.
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2007xh0830@hust.edu.cn.
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. alexpeng@hust.edu.cn.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zeng, W., Cai, J., Zhang, L., & Peng, Q. (2024). Iron Deposition in Parkinson’s Disease: A Mini-Review. Cellular and Molecular Neurobiology, 44(1). https://doi.org/10.1007/s10571-024-01459-4
Vancouver
Zeng W, Cai J, Zhang L, Peng Q. Iron Deposition in Parkinson’s Disease: A Mini-Review. Cellular and Molecular Neurobiology. 2024;44(1). doi:10.1007/s10571-024-01459-4
BibTeX
@article{Zeng2024,
author = {Zeng, Weiqi and Cai, Jin and Zhang, Lei and Peng, Qiwei},
title = {Iron Deposition in Parkinson’s Disease: A Mini-Review},
journal = {Cellular and Molecular Neurobiology},
year = {2024},
volume = {44},
number = {1},
doi = {10.1007/s10571-024-01459-4}
}
EUVIMED